WYOST 120 mg/1.7mL
denosumab · INJECTION · Sandoz Inc
No Recall History
Plain English
WYOST is a injection containing denosumab at 120 mg/1.7mL, taken subcutaneous. Manufactured by Sandoz Inc.
Key Facts
- Brand Name
- WYOST
- Generic Name
- denosumab
- NDC Code (Product)
61314-228- Manufacturer
- Sandoz Inc
- Strength
- 120 mg/1.7mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761362
- Drug Class
- RANK Ligand Inhibitor [EPC]
- Marketing Start
- 06/02/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is WYOST used for?
WYOST contains denosumab. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is WYOST a controlled substance?
WYOST is not classified as a controlled substance by the DEA.
What is the generic name for WYOST?
The generic name for WYOST is denosumab. There are 11 other brand versions of denosumab.
What is the NDC code for WYOST 120 mg/1.7mL?
The NDC (National Drug Code) for WYOST 120 mg/1.7mL is 61314-228, listed by Sandoz Inc.